Orthocell Has Strategy Validated With A$17 Million Raised to Fund US Launch of Remplir and Drive Commercialisation

Investing.com 10/31 09:14

Orthocell Ltd: 株主への年次報告書

ASX10/25 09:27

Orthocell Secures $17 Million in Share Placement to Launch Remplir Into US Market | ASX:OCC, OTC:ORHHF

Proactive Investors10/25 08:22

Orthocell Price Target Raised 3.1% to A$1.32/Share by Petra Capital

Dow Jones10/23 05:24

Orthocell Garners Regulatory Approval for Remplir in 'Gateway' Asian Market of Singapore

Investing.com 10/08 08:50

Orthocell Seeks Trading Halt Ahead of Announcement on Remplir Regulatory Approval

MT Newswires10/07 13:40